Home
Atea Pharmaceuticals AVIR paid Capitol Hill Consulting Group $50K for lobbying in Q2 2023 · Health Issues, Medical
Trade details
- Type
- Lobbying report
- Amount
- $50,000
- Quarter
- Q2 2023
- Client
- Atea Pharmaceuticals
- Reported
- 23/07/20
Up 0.0% from last quarter
What else happened in Atea Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 23/05/31~23/07/30Atea Pharmaceuticals's other lobbying reports
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
$10K
$10K
Reported 07/20
for Q2
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
$10K
$10K
Reported 04/20
for Q1
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
$10K
$10K
Reported 01/20
for Q4 2025
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
$10K
$10K
Reported 25/10/20
for Q3 2025
- Atea Pharmaceuticals
LobbyingAtea Pharmaceuticals
LobbyingAtea Pharmaceuticals
AVIR
Under $5,000
Under $5,000
Reported 24/10/20
for Q3 2024